STOCK TITAN

Horizon Space Acquisition II Right (HSPTR) 10-K Filings

HSPTR

Here are the 10-K annual reports from Horizon Space Acquisition II Corp. Right (HSPTR) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow HSPTR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HSPTR filings page.

Rhea-AI Summary

Horizon Space Acquisition II Corp. files its annual report outlining progress toward a merger and liquidity risks. The SPAC completed a $69,000,000 IPO and over-allotment in November 2024, placing the proceeds in a Nasdaq-listed trust structure. It entered a Business Combination Agreement with SL Bio Ltd., creating PubCo, whose ordinary shares are expected to trade on Nasdaq after closing. Shareholders approved the SL Bio deal and related governance changes, but 3,502,404 shares were submitted for redemption and a further 3,219,311 were redeemed at a later extension vote, sharply shrinking the public float. The company arranged a $7,800,000 PIPE for PubCo and multiple trust extensions funded via promissory notes. For 2025 it reported net income of $1,809,006, driven by $2,889,530 of trust interest, but year-end cash outside the trust was only $7,917 with a working capital deficit of $1,319,649, and management cites substantial doubt about continuing as a going concern without completing a business combination or obtaining further financing.